-
IMEIK Technology Development Co.,Ltd Acquires Majority Stake in REGEN Biotech via Joint Venture
•
China-based IMEIK Technology Development Co.,Ltd (SHE: 300896) announced the establishment of Imeik International Limited, a joint venture with Aisheng Shourui (HK) Limited. The primary objective of this joint venture is to acquire 85% stakes in South Korea-headquartered REGEN Biotech, Inc. for USD190 million. As part of this transaction, IMEIK will…
-
IMEIK Technology Receives NMPA Approval for Recombinant Human Hyaluronidase Clinical Study
•
China-based IMEIK Technology Development Co., Ltd (SHE: 300896) has announced receiving approval from the National Medical Products Administration (NMPA) to conduct a clinical study for its recombinant human hyaluronidase for injection. The study aims to explore the use of the drug to promote the diffusion of subcutaneous infusion as an…
